Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 176

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

Open access
Zhou, Tongqing, Doria-Rose, Nicole A., Cheng, Cheng, Stewart-Jones, Guillaume B.E., Chuang, Gwo-Yu, Chambers, Michael, Druz, Aliaksandr, Geng, Hui, McKee, Krisha, Kwon, Young Do, O’Dell, Sijy, Sastry, Mallika, Schmidt, Stephen D., Xu, Kai, Chen, Lei, Chen, Rita E., Louder, Mark K., Pancera, Marie, Wanninger, Timothy G., Zhang, Baoshan, Zheng, Anqi, Farney, S. Katie, Foulds, Kathryn E., Georgiev, Ivelin S., Joyce, M. Gordon, Lemmin, Thomas, Narpala, Sandeep, Rawi, Reda, Soto, Cinque, Todd, John-Paul, Shen, Chen-Hsiang, Tsybovsky, Yaroslav, Yang, Yongping, Zhao, Peng, Haynes, Barton F., Stamatatos, Leonidas, Tiemeyer, Michael, Wells, Lance, Scorpio, Diana G., Shapiro, Lawrence, McDermott, Adrian B., Mascola, John R., Kwong, Peter D.·2017·Cell Reports

Abstract

While the HIV-1-glycan shield is known to shelter Env from the humoral immune response, its quantitative impact on antibody elicitation has been unclear. Here, we use targeted deglycosylation to measure the impact of the glycan shield on elicitation of antibodies against the CD4 supersite. We engineered diverse Env trimers with select glycans removed proximal to the CD4 supersite, characterized their structures and glycosylation, and immunized guinea pigs and rhesus macaques. Immunizations yielded little neutralization against wild-type viruses but potent CD4-supersite neutralization (titers 1: >1,000,000 against four-glycan-deleted autologous viruses with over 90% breadth against four-glycan-deleted heterologous strains exhibiting tier 2 neutralization character). To a first approximation, the immunogenicity of the glycan-shielded protein surface was negligible, with Env-elicited neutralization (ID 50 ) proportional to the exponential of the protein-surface area accessible to antibody. Based on these high titers and exponential relationship, we propose site-selective deglycosylated trimers as priming immunogens to increase the frequency of site-targeting antibodies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2017.04.013

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 176

Metadata

Authors
Zhou, T., Doria-Rose, N. A., Cheng, C., Stewart-Jones, G. B. E., Chuang, G.-Y., Chambers, M., Druz, A., Geng, H., McKee, K., Kwon, Y. D., O’Dell, S., Sastry, M., Schmidt, S. D., Xu, K., Chen, L., Chen, R. E., Louder, M. K., Pancera, M., Wanninger, T. G., Zhang, B., Zheng, A., Farney, S. K., Foulds, K. E., Georgiev, I. S., Joyce, M. G., Lemmin, T., Narpala, S., Rawi, R., Soto, C., Todd, J.-P., Shen, C.-H., Tsybovsky, Y., Yang, Y., Zhao, P., Haynes, B. F., Stamatatos, L., Tiemeyer, M., Wells, L., Scorpio, D. G., Shapiro, L., McDermott, A. B., Mascola, J. R., & Kwong, P. D.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2017-04
Volume
19
Issue
4
Pages
719-732
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2607794913
Cited by
176
References
7
FWCI
12.19
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. https://app.cochat.ai/papers/10.1016/j.celrep.2017.04.013
The paper
Zhou, T., Doria-Rose, N. A., Cheng, C., Stewart-Jones, G. B. E., Chuang, G.-Y., Chambers, M., Druz, A., Geng, H., McKee, K., Kwon, Y. D., O’Dell, S., Sastry, M., Schmidt, S. D., Xu, K., Chen, L., Chen, R. E., Louder, M. K., Pancera, M., Wanninger, T. G., . . . Kwong, P. D. (2017). Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. Cell Reports. https://doi.org/10.1016/j.celrep.2017.04.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.